Left atrial appendage closure noninferior to DOACs in preventing AF-related CV, neurological events
Percutaneous left atrial appendage closure (LAAC) is not inferior to direct oral anticoagulants (DOACs) in the prevention of major atrial fibrillation (AF)-related cardiovascular, neurological, and bleeding events, results of a recent study have shown.
Left atrial appendage closure noninferior to DOACs in preventing AF-related CV, neurological events
03 Jul 2020